Enhancement by vasoactive intestinal peptide of γ-interferon production by antigen-stimulated type 1 helper T cells

被引:23
作者
Jabrane-Ferrat, N
Bloom, D
Wu, A
Li, L
Lo, D
Sreedharan, SP
Turck, CW
Goetzl, EJ
机构
[1] Univ Calif San Francisco, Med Ctr, Dept Med, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Med Ctr, Dept Microbiol Immunol, San Francisco, CA 94143 USA
[3] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA
[4] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
关键词
neuropeptide; receptors; G-proteins; cytokines; lymphocytes;
D O I
10.1096/fasebj.13.2.347
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vasoactive intestinal peptide (VIP) is a neuroendocrine mediator in immune tissues that affects many T cell functions through two homologous high-affinity G-protein-coupled receptors, termed VIPR1 and VIPR2. Antigen-stimulated secretion of gamma-interferon (IFN-gamma) by sperm whale myoglobin-specific Th1 cells of DBA/2 mouse I-E(d)-restricted clones, which express VIPR1 and VIPR2, was enhanced by 10(-10) M to 10(-7) M VIP. Enhancement of IFN-gamma secretion reached a mean maximum of fourfold for VIP and threefold for a VIPR2-selective agonist, without any effect of a VIPR1-selective agonist. Secretion of IFN-gamma by PMA and ionomycin-stimulated clones of Th1 cells was not altered by VIP. Antigen-stimulated secretion of IFN-gamma by T cell receptor-transgenic, influenza hemagglutinin-specific, and cytokine-differentiated mouse lymph node Th1 cells, which also express VIPR1 and VIPR2, was enhanced by 10(-10) M to 10(-8) M VIP. Enhancement of IFN-gamma secretion increased to a maximum of 14-fold for VIP, 14-fold for the VIPR2-selective agonist, and 20-fold for the VIPR1-selective agonist. In contrast to VIP suppression of interleukin production and lack of effect on IFN-gamma production by T cells stimulated with anti-CD3 antibody or a mitogenic lectin, generation of IFN-gamma by antigen-stimulated T cells is enhanced significantly by physiological concentrations of VIP.
引用
收藏
页码:347 / 353
页数:7
相关论文
共 38 条
[1]  
APNKHANIYA R, 1998, FASEB J, V12, P119
[2]  
BARNES D, 1991, QUAL ASSUR GOOD PRAC, V1, P1
[3]   VASOACTIVE INTESTINAL POLYPEPTIDE MODULATES THE IN-VITRO IMMUNOGLOBULIN-A PRODUCTION BY INTESTINAL LAMINA PROPRIA LYMPHOCYTES [J].
BOIRIVANT, M ;
FAIS, S ;
ANNIBALE, B ;
AGOSTINI, D ;
FAVE, GD ;
PALLONE, F .
GASTROENTEROLOGY, 1994, 106 (03) :576-582
[4]   THE PRESUMPTIVE CDR3 REGIONS OF BOTH T-CELL RECEPTOR ALPHA-CHAIN AND BETA-CHAIN DETERMINE T-CELL SPECIFICITY FOR MYOGLOBIN PEPTIDES [J].
DANSKA, JS ;
LIVINGSTONE, AM ;
PARAGAS, V ;
ISHIHARA, T ;
FATHMAN, CG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (01) :27-33
[5]   ON THE VARIOUS MANIFESTATIONS OF SPONTANEOUS AUTOIMMUNE DIABETES IN RODENT MODELS [J].
DEGERMANN, S ;
REILLY, C ;
SCOTT, B ;
OGATA, L ;
VONBOEHMER, H ;
LO, D .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (12) :3155-3160
[6]   Differential expression of vasoactive intestinal peptide receptors 1 and 2 (VIP-R1 and VIP-R2) mRNA in murine lymphocytes [J].
Delgado, M ;
Martinez, C ;
Johnson, MC ;
Gomariz, RP ;
Ganea, D .
JOURNAL OF NEUROIMMUNOLOGY, 1996, 68 (1-2) :27-38
[7]   MULTIPLE NEUROPEPTIDES IN NERVES SUPPLYING MAMMALIAN LYMPH-NODES - MESSENGER CANDIDATES FOR SENSORY AND AUTONOMIC NEUROIMMUNOMODULATION [J].
FINK, T ;
WEIHE, E .
NEUROSCIENCE LETTERS, 1988, 90 (1-2) :39-44
[8]   Vasoactive intestinal peptide induces S alpha/S mu switch circular DNA in human B cells [J].
Fujieda, S ;
Waschek, JA ;
Zhang, K ;
Saxon, A .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (07) :1527-1532
[9]   VASOACTIVE-INTESTINAL-PEPTIDE DOWN-REGULATES THE EXPRESSION OF IL-2 BUT NOT OF IFN-GAMMA FROM STIMULATED MURINE T-LYMPHOCYTES [J].
GANEA, D ;
SUN, L .
JOURNAL OF NEUROIMMUNOLOGY, 1993, 47 (02) :147-158
[10]   Regulatory effects of vasoactive intestinal peptide on cytokine production in central and peripheral lymphoid organs [J].
Ganea, D .
ADVANCES IN NEUROIMMUNOLOGY, 1996, 6 (01) :61-74